NEW YORK (GenomeWeb News) – Thirteen European research institutes and universities will work together using €6 million ($7.8 million) in funding from the European Commission to develop biomarker-based technologies for determining the health status of kidney transplants.

Led by France's National Institute of Health and Medical Research, or INSERM, the Biomarkers of Renal Graft Injuries in Kidney Allograft Recipients consortium includes several partnering institutes in France, Belgium, and Germany, and one in Sweden, INSERM said yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.